In vivo and in vitro studies demonstrate that PON-1 protects against the damage caused by hyperhomocysteinemia associated with the development of atherosclerosis and vascular endothelial dysfunction [61], age-related macular degeneration [62], multiple sclerosis [63] and cancer [28]. The gene discussed is PON1; the disease is multiple sclerosis.